June 20, 2007
Strattice™ Opens up the Cosmetic Market
Analysis of:
Lifecell Corporation receives 510(k) clearance for tissue repair product | www.pipelinereview.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Implications: Alloderm™ is a human donor product. Strattice™ is porcine and using Strattice™ for cosmetic uses opens up new promotional possibilities.
Analysis: The families of cadaveric donors of Alloderm™ are not generally pleased that their relatives tissue is now enhancing someone else cosmetically. Reconstructive uses are an easier sell in allowing human donor tissue to be harvested. Having a porcine product means that cosmetic applications may be promoted and the benefits should be similar to human derived products. This also removes concern about human derived diseases being passed with the graft
Analysis: The families of cadaveric donors of Alloderm™ are not generally pleased that their relatives tissue is now enhancing someone else cosmetically. Reconstructive uses are an easier sell in allowing human donor tissue to be harvested. Having a porcine product means that cosmetic applications may be promoted and the benefits should be similar to human derived products. This also removes concern about human derived diseases being passed with the graft
Report a Concern
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Painkiller Risk Found for Heart Patients
www.nytimes.com
FDA Asks if Pain Pill Is Tamper-Proof
online.wsj.com
Merck KGaA: Overall Survival in First-Line NSCLC Reaches 15 Months
www.pipelinereview.com
Hospitals See Drop in Paying Patients
www.nytimes.com
Gardasil, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
www.fiercebiotech.com
Is Celebrex Next ?
November 18, 2008
Will contact lens solutions cost more to ship and store?
November 13, 2008
Economy's impact on healthcare facilities
November 13, 2008
Tamper Proof Narcotic Pain pill? YES
November 13, 2008
A closer look
November 11, 2008

